Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: CATALYST Reveals High Prevalence of Hypercortisolism in T2D
Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss the newly published findings from the CATALYST trial, a prospective, observational study establishing the prevalence of hypercortisolism among…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.